MPM BioImpact

We are a world-leading biotechnology investment firm with three decades of experience creating and investing in innovative companies seeking to deliver transformative therapies to patients.

At our core, we are company creators. Our dedicated team of Entrepreneur Partners provides deep domain expertise in research and development, intellectual property, clinical strategy, and commercialization – elements that we believe are crucial for successful company building.

MPM BioImpact combines the 30+ year track record of the MPM CAPITAL^® services and offerings in biotech venture capital with BioImpact’s dedication to impact and 10+ years of experience in public investing. Together, we manage over $3 billion AUM across early-stage venture funds, private/public impact funds, and a public equities fund.